Leveraging generative AI on AWS to transform life sciences
IBM Big Data Hub
JULY 19, 2023
Life sciences industry has—for decades now—moved from the traditional discovery-based drug development to target market-based drug development paradigm. Yet, it is burdened by long R&D cycles and labor-intensive clinical, manufacturing and compliancy regimens. in 10 years, from 2012 to 2022.
Let's personalize your content